4D Molecular Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
4D Molecular Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • 4D Molecular Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $21.8M, a 82.1% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $21.8M +$9.81M +82.1% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $10.7M -$1.66M -13.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $11.1M -$1.58M -12.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.5M -$1.55M -11.8% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $12M -$1.51M -11.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $12.4M -$1.47M -10.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $12.7M -$1.48M -10.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $13.1M -$1.48M -10.1% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $13.5M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $13.8M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $14.2M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $14.6M +$14.6M Dec 31, 2021 10-K 2023-03-15
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.